[go: up one dir, main page]

WO1993000936A1 - A barrier for tissue separation - Google Patents

A barrier for tissue separation Download PDF

Info

Publication number
WO1993000936A1
WO1993000936A1 PCT/SE1992/000494 SE9200494W WO9300936A1 WO 1993000936 A1 WO1993000936 A1 WO 1993000936A1 SE 9200494 W SE9200494 W SE 9200494W WO 9300936 A1 WO9300936 A1 WO 9300936A1
Authority
WO
WIPO (PCT)
Prior art keywords
sealing agent
membrane
poly
barrier
tissue
Prior art date
Application number
PCT/SE1992/000494
Other languages
French (fr)
Inventor
Bengt ÅGERUP
Original Assignee
Medinvent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinvent filed Critical Medinvent
Priority to CA002113091A priority Critical patent/CA2113091C/en
Priority to EP92916064A priority patent/EP0596940A1/en
Publication of WO1993000936A1 publication Critical patent/WO1993000936A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Definitions

  • the present invention relates to a barrier for tissue separation. More precisely, the invention relates to a barrier comprising a biologically degradable membrane.
  • Thigh muscles can after exterior violence be hurt so seriously that an incorrect healing arises with formation of fibrous connective tissue and growing together of adjacent muscle groups. Such conditions are usually not improvable with movement therapy and massage.
  • cysts can be stimulated to develop.
  • a protective dressing is arranged about the nerve in the following way.
  • a bone recess had developped in the branching site 4 of a molar tooth 1 leading to loss of the attachment. Previous clearance of the area did not lead to any improvment of the condition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)

Abstract

The present invention relates to a barrier and a method for tissue separation. The barrier comprises a biodegradable membrane and a biodegradable sealing agent to seal said membrane against an injured tissue area.

Description

A BARRIER FOR TISSUE SEPARATION
The present invention relates to a barrier for tissue separation. More precisely, the invention relates to a barrier comprising a biologically degradable membrane.
A large and general problem within medicine is that injured or defective tissue heals incorrectly in spite of implemented surgical corrective measures. The most common case is about post- surgical growing together of organs or organ parts which in the normal case shall be able to move freely in relation to each other. Another usual example is overgrowth of an injured area which is the case, for example, in association with excessive scar formation in the skin, adherences in about every organ part and strictures in hollow organs like intestine, uterus and ureter. Many cases of incorrect healing depend on influence from foreign cells in excess. An example of this is fibroblasts which in excess form far too much collagen.
Some known ways to try to solve these problems are firstly to perform the surgical reparair as little injuring as possible and secondly to insert barriers between the relevant organ parts. These barriers have included the patient's own fat as well as collagen materials or surgical web.
It is also known to use biologically degradable membranes between the organ parts but it has been difficult to arrange these tightly against the tissue and thereby protect the same from the environmental influences.
In prior art, sutures and screws have been used to attach biologically degradable membranes against injured tissue, see, for example, EP A2 0349 505. However, these solutions are complicated and unreliable because the attachement means used do not function satifactorily. Either they are complicated and time consuming or unreliable because they are detached from their attachment sites. The present invention solves the problem with incorrect healing of the injured or defective tissue in that the injured or defective tissue is blocked from surrounding healthy tissue, whereby healing without complications is obtained. This is obtained in that the injured area is temporarily isolated from the influence of surrounding tissue and cells. According to the present invention the injured tissue section is isolated by a barrier. The barrier comprises a biologically degradable membrane and a biologically degradable sealing agent, the sealing agent being used to seal the membrane against an injured tissue area. The membrane should be of a non-porous type, ie. one that does not permit cells to pass therethrough.
In principle any biologically degradable material can be used for the membrane and sealing agent, respectively. Examples of suitable biologically degradable materials are polyglycolide and co-polymers thereof, polylactides and co-polymers thereof, poly- β-hydroxybut rate and co-polymerisates thereof, poly-p-dioxanon, poly-δ-valerolactone, poly-6-caprolactone, methyl-metacrylate-N- vinyl pyrrolidine co-polymers, polyesther amides, polyesters of oxalic acid, polydihydropyranes, polyalcyl-2-cyanoacrylates, polyurethanes, polyvinylalcohol, polypeptides, poly-β-maleicacid and poly-β-alcanoic acids.
The invention will now be described below in more detail in association with some examples of how to use the invention.
Example 1:
Prevention of growing together of meninxs
After surgery in the brain it is desirable to seal the meninx while the same is allowed to heal spontaneously. According to the invention a rectangular piece of lactide membrane is cut in a shape so that it covers the opening caused by the surgery. A thin strip of polylactide (40%) dissolved in acetone is applied around the opening. The membrane is laid in position and is gently pressed to adhere against the meninx. After a short time of aering the outer portions of the wound are sealed.
Example 2:
Prevention of growing together of muscle groups
Thigh muscles can after exterior violence be hurt so seriously that an incorrect healing arises with formation of fibrous connective tissue and growing together of adjacent muscle groups. Such conditions are usually not improvable with movement therapy and massage.
After surgical removal of the incorrect healing with accompanying control of the bleeding, a thin glue strand (40% polylactide in acetone) is applied around the injury on the connective tissue capsule, whereafter a suitably dimensioned membrane piece is arranged over the deficiency and against the glue.
Example 3:
Prevention of growing together between nerve and bone
On peripher nerves, for example nervus saphenous in the tibia area, cysts can be stimulated to develop. In connection with a surgical removal of the cyst a protective dressing is arranged about the nerve in the following way.
A piece of lactide membrane is cut so that it is possible to wind one and a half turns around the nerve and so that its length is exceeding that of the cyst with 10 mm. A thin glue strand (40% polylactide in acetone) is arranged partly on the peripher ends of the nerve and partly on the outer edge of the longitudinal joint where the lactide membrane is to be joined together. After applying of the membrane, the glue portions are pressed together and are allowed to dry during 10-15 minutes, whereafter the incision site is sealed. The healing occurs with the retained nerve function and without pressure pain or other complication signs.
Example 4:
Prevention of growing together of bones and granulation tissue
In this example reference is made to the accompanying drawing. Figure 1 shows a tooth 1 being fastened in bone 2. Beneath the crown of the tooth there is gingiva or epithelium 3, covering the bone 2.
A bone recess had developped in the branching site 4 of a molar tooth 1 leading to loss of the attachment. Previous clearance of the area did not lead to any improvment of the condition.
The gingiva 3 was freed from the deficiency, tartar depositions were removed and the worst granulation tissue was removed.
A polylactide membrane 5 was cut into a shape so that it substantially followed the tooth profile over the deficiency and in the periphery reached to the bone edge. The part 6 of the tooth being on the same height as the gingiva 3 was provided with a glue strand (about 40% lactide in acetone). The membrane 5 was put adjacent the tooth 1 so that the glue connected it with the tooth. The outer edges of the membrane were put under the backfolded gingiva 3 but over the bone edge. The mucous membrane was folded back and fastened with a couple of sutures over the deficiency. The epithelia is now allowed to grow without influence from the environment in the mouth cavity.
Within about 6 weeks the injury is healed and an apparent improvement of the attachment is obtained. After about three months the bone deficiency is beginning to fill out. In the above examples lactide has been used both for the membrane and the sealing agent, above denoted "glue". It is ,however, understood that also other biologically degradable materials can be used. The sealing agent should be soluble in a physiologically acceptable solvent and liquid at the application of the membrane, and thereafter the sealing agent converts to a solid condition.
The rate with which the membrane is degraded can be varied in that the concentration of lactide or any other degradable polymer in the membrane is varied.
Preferably membranes and sealing agents of the same kind are chosen, to obtain a common biological degradation rate.
By the barrier according to the invention, healing of injured and/or defective tissue is enabled in a way that was previously not possible.

Claims

1. A barrier for tissue separation comprising a biodegradable membrane, wherein it also comprises a biodegradable sealing agent to seal said membrane against an injured tissue area.
2. A barrier according to claim 1, wherein said sealing agent and said membrane comprise material selected from the group consisting of polyglycolide and co-polymers thereof, polylactides and co-polymers thereof, poly-β-hydroxybutyrate and co-polymeri- sates thereof, poly-p-dioxanon, poly-δ-valerolactone, poly-6- caprolactone, methyl-metacrylate-N-vinyl pyrrolidine co-polymers, polyesther amides, polyesters of oxalic acid, polydihydropyranes, polyalcyl-2-cyanoacrylates, polyurethanes, polyvinylalcohol, polypeptides, poly-β-maleic acid and poly-β-alcanoic acids.
3. A barrier according to claim 1 or 2, wherein said sealing agent is dissolved in a solvent.
4. A barrier according to claim 1 or 2, wherein said sealing agent is heated before sealing said membrane.
5. A barrier according to one ore more of the claims 1-4, wherein said sealing agent and said membrane comprise the same material.
6. A barrier according to claim 5, wherein said sealing agent and said membrane comprise poylactide.
7. A method to treat injured or defective tissue to avoid that it heals incorrectly, comprising attaching of a biologically degradable membrane against said injured tissue by a biologically degradable sealing agent.
8. A method according to claim 7, comprising dissolving said sealing agent in a solvent.
9. A method according to claim 7, comprising heating of said sealing agent before attaching said membrane.
10. Use of a barrier comprising a biologically degradable membrane and a biodegradable sealing agent for tissue separation.
_ _
AMENDED CLAIMS
[received by the International Bureau on 4 December 1992 (04.12.92); original claim 10 deleted; remaining claims unchanged (2 pages)]
1. A barrier for tissue separation comprising a biodegradable membrane, wherein it also comprises a biodegradable sealing agent to seal said membrane against an injured tissue area.
2. A barrier according to claim 1, wherein said sealing agent and said membrane comprise material selected from the group consisting of polyglycolide and co-polymers thereof, polylactides and co-polymers thereof, poly-β-hydroxybutyrate and co-polymeri- sates thereof, poly-p-dioxanon, poly-δ-valerolactone, poly-6- caprolactone, methyl-metacrylate-N-vinyl pyrrolidine co-polymers, polyesther amides, polyesters of oxalic acid, polydihydropyranes, polyalcyl-2-cyanoacrylates, polyurethanes, polyvinylalcohol, polypeptides, poly-β-maleic acid and poly-β-alcanoic acids.
3. A barrier according to claim 1 or 2, wherein said sealing agent is dissolved in a solvent.
4. A barrier according to claim 1 or 2, wherein said sealing agent is heated before sealing said membrane.
5. A barrier according to one ore more of the claims 1-4, wherein said sealing agent and said membrane comprise the same material.
6. A barrier according to claim 5, wherein said sealing agent and said membrane comprise poylactide.
7. A method to treat injured or defective tissue to avoid that it heals incorrectly, comprising attaching of a biologically degradable membrane against said injured tissue by a biologically degradable sealing agen .
8. A method according to claim 7, comprising dissolving said sealing agent in a solvent. 9. A method according to claim 7, comprising heating of said sealing agent before attaching said membrane.
PCT/SE1992/000494 1991-06-17 1992-07-01 A barrier for tissue separation WO1993000936A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002113091A CA2113091C (en) 1991-06-17 1992-07-01 A barrier for tissue separation
EP92916064A EP0596940A1 (en) 1991-06-17 1992-07-01 A barrier for tissue separation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101867A SE469109B (en) 1991-06-17 1991-06-17 SEALANT CONTAINING A MEMBRANE AND A Glue, WHICH ARE BADA BIODEGRADABLE
SE9101867-1 1991-07-10

Publications (1)

Publication Number Publication Date
WO1993000936A1 true WO1993000936A1 (en) 1993-01-21

Family

ID=20383072

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1992/000494 WO1993000936A1 (en) 1991-06-17 1992-07-01 A barrier for tissue separation

Country Status (5)

Country Link
EP (1) EP0596940A1 (en)
AU (1) AU2331492A (en)
CA (1) CA2113091C (en)
SE (1) SE469109B (en)
WO (1) WO1993000936A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021307A1 (en) * 1993-03-15 1994-09-29 Medinvent Matrix composition for tissue reinforcement and/or filling
CN109876192A (en) * 2019-03-13 2019-06-14 东华大学 A kind of bone repair membrane and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603695A (en) * 1983-07-05 1986-08-05 Japan Medical Supply Co., Ltd. Use of molded polymeric material for preventing adhesion of vital tissues
EP0349505A2 (en) * 1988-06-27 1990-01-03 Astra Aktiebolag A novel surgical material
WO1990007308A1 (en) * 1988-12-23 1990-07-12 Procordia Oratech Ab Surgical barrier

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603695A (en) * 1983-07-05 1986-08-05 Japan Medical Supply Co., Ltd. Use of molded polymeric material for preventing adhesion of vital tissues
EP0349505A2 (en) * 1988-06-27 1990-01-03 Astra Aktiebolag A novel surgical material
WO1990007308A1 (en) * 1988-12-23 1990-07-12 Procordia Oratech Ab Surgical barrier

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021307A1 (en) * 1993-03-15 1994-09-29 Medinvent Matrix composition for tissue reinforcement and/or filling
CN109876192A (en) * 2019-03-13 2019-06-14 东华大学 A kind of bone repair membrane and preparation method thereof

Also Published As

Publication number Publication date
SE469109B (en) 1993-05-17
CA2113091A1 (en) 1993-01-21
CA2113091C (en) 2004-03-16
SE9101867L (en) 1993-01-11
EP0596940A1 (en) 1994-05-18
SE9101867D0 (en) 1991-06-17
AU2331492A (en) 1993-02-11

Similar Documents

Publication Publication Date Title
DE60131577T2 (en) Absorbable micro-membrane to reduce scar tissue during the healing process
US20070042326A1 (en) Collagen antral membrane expander
AU2001245671A1 (en) Resorbable micro-membrane for attenuation of scar tissue
CA2184916A1 (en) Use of fibroblast growth factors to stimulate bone growth
US20100266662A1 (en) Methods of promoting enhanced healing of tissues after cardiac surgery
Lindorf Osteoplastic surgery of the sinus maxillaris—the “bone lid”-method
US5607689A (en) Latex element designed to achieve guided tissue regeneration in periodontal dental therapy
Shuker Spontaneous regeneration of the mandible in a child a sequel to partial avulsion as a result of a war injury
CA2113091C (en) A barrier for tissue separation
Burstein et al. Surgical correction of severe scaphocephalic deformities
Prein et al. Stable internal fixation of midfacial fractures
Stelnicki et al. A method for repairing zygomatic arch fractures using a hydroxyapatite cement paste (Bonesource)
RU2207077C2 (en) Method for preventing contracture formation in hip joint after its total repair with endoprosthesis
Mann et al. minimal access surgery for cochlear implantation with MED-EL devices
Schultz et al. THE TREATMENT OF FACIAL PARALYSIS BY TANTALUM WIRE SUSPENSION: PRELIMINARY REPORT
SU1745101A3 (en) Dental implant
SU1438725A1 (en) Method of treatment of false joints
SU1694114A1 (en) Method for treating upper jawbone fracture
SU1179982A1 (en) Arrangement for fixing bone fragments
SU1296135A1 (en) Method of treatment of congenital deviation of interior section of foot
SU1261636A1 (en) Method of plasty of anterior wall of maxillary sinus
SU1456101A1 (en) Method of treatment of fractures of upper jaw
SU1174003A1 (en) Method of surgical treatment of high fractures of condylar process of the lower jaw
SU1147359A1 (en) Method of osteosynthesis of upper jaw
KLEITSCH Vitallium in Reconstructive Surgery About the Face

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MG MW NO PL RO RU SD US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2113091

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1992916064

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992916064

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1992916064

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992916064

Country of ref document: EP